Ask Congress to prioritize funding for antimicrobial resistance.

 Antimicrobial resistance is one of the most pressing public health crises we face today—both nationally and globally. Encouragingly, past investments in the Centers for Disease Control and Prevention (CDC) have yielded measurable success in reversing trends for some of the most common healthcare-associated infections (HAIs), including those caused by multidrug-resistant organisms (MDROs). However, CDC has recently experienced significant federal funding cuts, including a major reduction in its workforce. Alarmingly, the agency is also facing the prospect of further cuts in the Fiscal Year 2026 budget, which could severely compromise its ability to continue this vital work.

We cannot afford to let existing federal funding for antimicrobial resistance erode. Doing so would undermine our ability to maintain a safe healthcare environment for patients. The stakes are high, and continued investment is essential to safeguard public health and ensure that medical care remains both safe and effective.

We urge you to contact your Congressional delegation and advocate for prioritizing antimicrobial resistance funding in the CDC’s FY 2026 budget. Sustained investment is critical. Without it, we risk rising healthcare costs driven by increased complications from MDROs and prolonged hospital stays.

To stay ahead of this escalating threat, your voice and support are essential. Please consider personalizing the draft letter to the right by sharing your story or professional expertise—your perspective can make a powerful difference.

Thank you for your continued advocacy.